NRG eVgo, a subsidiary of NRG Energy, Inc. (NYSE:NRG) will roll out the EZ-Charge (SM)platform, a first-of-its-kind initiative that will offer electric vehicle (EV) drivers the ability to access multiple EV charging networks with a single all-access card. NRG Energy Inc (NYSE:NRG) net profit margin is -6.40% and weekly performance is -0.09%. On last trading day company shares ended up $33.65. Analysts mean target price for the company is $39.09. NRG Energy Inc (NYSE:NRG) distance from 50-day simple moving average (SMA50) is 4.36%.
F5 Networks Inc (NASDAQ:FFIV) announced that it has acquired Defense.Net, Inc., a privately-held provider of cloud-based security services for protecting data centers and Internet applications from distributed denial-of-service (DDoS) attacks. The advanced technologies and operational experience shared between the two companies will expand F5’s portfolio of security solutions for defense against Internet-based DDoS attacks on networks, data centers, and applications. Defense.Net’s high-capacity cloud service is complementary to F5’s existing on-premise DDoS Protection capabilities. F5 Networks, Inc. (NASDAQ:FFIV) shares advanced 0.60% in last trading session and ended the day on $107.63. Gross Margin is 82.40% and its return on assets is 12.90%. F5 Networks, Inc. (NASDAQ:FFIV) quarterly performance is -2.40%.
Duke Energy Corp (NYSE:DUK) announced it has signed an agreement with the U.S. Environmental Protection Agency (EPA) regarding cleanup of the coal ash release into the Dan River that occurred at the company’s retired Dan River coal-fired power plant in Eden, N.C., on Feb. 2, 2014. Duke Energy Corp (NYSE:DUK) shares moved up 0.89% in last trading session and was closed at $70.55, while trading in range of $70.01 – $70.64. Duke Energy Corp (NYSE:DUK) year to date (YTD) performance is 4.50%.
ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) a biopharmaceutical company focused on the development and commercialization of new cancer therapies, announced results demonstrating the potent anti-tumor and anti-cancer stem cell (CTC) effects of Ad-RTS-IL-12 in a glioma (brain cancer) model, and in other preclinical and clinical settings. Ad-RTS-IL-12 is a novel DNA-based therapeutic candidate for the controlled expression of IL-12, an important protein for stimulating an anti-cancer T cell immune response. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) ended the last trading day at $3.12. Company weekly volatility is calculated as 6.39% and price to cash ratio as 5.20. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) showed a positive weekly performance of 0.32%.
Nike Inc (NYSE:NKE) will also be keeping close tabs on the draft lottery, as this will go a long way in determining where some of its primary targets could be playing next season. Nike Inc (NYSE:NKE) net profit margin is 9.90% and weekly performance is 2.66%. On last trading day company shares ended up $74.88. Analysts mean target price for the company is $82.39. Nike Inc (NYSE:NKE) distance from 50-day simple moving average (SMA50) is 1.01%.
Leave a Reply